相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metal complexes with new types of chiral ligands based on natural terpenes
S. V. Larionov
RUSSIAN JOURNAL OF COORDINATION CHEMISTRY (2012)
Tumor cellular proteasome inhibition and growth suppression by 8-hydroxyquinoline and clioquinol requires their capabilities to bind copper and transport copper into cells
Shumei Zhai et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2010)
Inhibition of Tumor Proteasome Activity by Gold-Dithiocarbamato Complexes via Both Redox-Dependent and -Independent Processes
Xia Zhang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
Casiopeina IIgly-induced oxidative stress and mitochondrial dysfunction in human lung cancer A549 and H157 cells
Remy Kachadourian et al.
TOXICOLOGY (2010)
COPPER AND ANGIOGENESIS: UNRAVELLING A RELATIONSHIP KEY TO CANCER PROGRESSION
Lydia Finney et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2009)
Disulfiram promotes the conversion of carcinogenic cadmium to a proteasome inhibitor with pro-apoptotic activity in human cancer cells
Lihua Li et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2008)
Thioamido coordination in a thioxo-1,2,4-triazole copper(II) complex enhances nonapoptotic programmed cell death associated with copper accumulation and oxidative stress in human cancer cells
Saverio Tardito et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts
Vesna Milacic et al.
CANCER RESEARCH (2006)
Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity
Di Chen et al.
CANCER RESEARCH (2006)
Celastrol, a triterpene extracted from the Chinese Thunder of God Vine, is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice
Huanjie Yang et al.
CANCER RESEARCH (2006)
Mitochondria: a target for cancer therapy
JS Armstrong
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Inhibition of prostate cancer cellular proteasome activity by a pyrrolidine dithiocarbamate-copper complex is associated with suppression of proliferation and induction of apoptosis
D Chen et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2005)
Differential modulation of normal and tumor cell proliferation by reactive oxygen species
C Nicco et al.
BIOMEDICINE & PHARMACOTHERAPY (2005)
Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells
KG Daniel et al.
BREAST CANCER RESEARCH (2005)
Organic copper complexes as a new class of proteasome inhibitors and apoptosis inducers in human cancer cells
KG Daniel et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Copper storage diseases: Menkes, Wilson's, and cancer
KG Daniel et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2004)
Oxidation of indole-3-acetic acid by horseradish peroxidase induces apoptosis in G361 human melanoma cells
DS Kim et al.
CELLULAR SIGNALLING (2004)
Potential for proteasome inhibition in the treatment of cancer
J Adams
DRUG DISCOVERY TODAY (2003)
The role of the ubiquitination-proteasome pathway in breast cancer - Applying drugs that affect the ubiquitin-proteasome pathway to the therapy of breast cancer
RZ Orlowski et al.
BREAST CANCER RESEARCH (2003)
Trace elements in human physiology and pathology. Copper
H Tapiero et al.
BIOMEDICINE & PHARMACOTHERAPY (2003)
The proteasome: a novel target for cancer chemotherapy
JB Almond et al.
LEUKEMIA (2002)
Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs
Stephen B. Fox et al.
LANCET ONCOLOGY (2001)
Angiogenesis inhibitors - New agents in cancer therapy
CJ Ryan et al.
DRUGS & AGING (2000)
Tumour vasculature as a target for anticancer therapy
MM Eatock et al.
CANCER TREATMENT REVIEWS (2000)
Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression
BY Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Angiogenesis: New targets for the development of anticancer chemotherapies
M Gourley et al.
CURRENT PHARMACEUTICAL DESIGN (2000)
分享论文
